Skip to main content

Greenberg Traurig’s David Dykeman Leads ‘IP Strategy Workshop’ for MassMEDIC MedTech IGNITE

BOSTON July 20, 2020David J. Dykeman, co-managing shareholder of Greenberg Traurig, LLP’s Boston office and co-chair of the firm’s Life Sciences & Medical Technology Group will serve as a faculty member and advisor for the Massachusetts Medical Device Industry Council’s (MassMEDIC) MedTech IGNITE virtual accelerator program. Dykeman and Lisa Adams of Mintz Levin will present an “IP Strategy Workshop” to the program’s cohort members on July 22, 2020.  

According to its website, MedTech IGNITE is a “training, mentorship and networking program designed to attract and nurture the next generation of Boston-area medtech founders and entrepreneurs.”

Dykeman is a registered patent attorney with more than 23 years of experience in patent and intellectual property law. His practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman has served on the Board of Directors of MassMEDIC for over six years.

About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to approximately 70 attorneys practicing in the areas of bankruptcy and restructuring, corporate, emerging technology, energy, environmental, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2200 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: Twitter: @GT_Law.